An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)

To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine

Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)

The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study

A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease

A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia

Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine

Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)